How Microplastics May Trigger Weight Gain
Dr. Thompson discussed how microplastics may trigger weight gain by disrupting hormones, offering insights for holistic weight management
Explore the latest news and coverage about Bariendo
Dr. Thompson discussed how microplastics may trigger weight gain by disrupting hormones, offering insights for holistic weight management
Dr. Thompson recommends assessing bone density prior to weight-loss medication use, considering surgical options, and emphasizes a sustained medication plan.
Dr. Chris Thompson is encouraging people to weigh the pros and cons before taking the medicine that's becoming the quick fix for weight loss.
Dr. Chris Thompson advises against compounded semaglutide, citing safety concerns and lack of FDA review.
JAMA study compares economics of bariatric surgery vs. GLP-1 meds, offering insights on cost-effectiveness for Bariendo's procedures.
The Harvard Gazette highlights Dr. Christopher Thompson’s study, which found ESG more cost-effective than weight loss drugs.
Dr. Pichamol Jirapinyo and Laurent Kort discussed the effectiveness of calorie counting for weight loss and reviewed various calorie-tracking apps.
Healio Gastroenterology features a JAMA study finding endoscopic sleeve gastroplasty more cost-effective than semaglutide.
HealthCentral covered Gwen Johnson, a Bariendo patient, who chose ESG over costly GLP-1 meds, losing 40 pounds post-procedure.
Dr. Thompson highlights ESG as a more cost-effective and effective weight loss option than semaglutide.
Everyday Health features a study finding endoscopic sleeve gastroplasty leads to more weight loss and lower medical costs over five years than semaglutide.
Healthline covered Dr. Christopher Thompson and Dr. Pichamol Jirapinyo's study on ESG's cost-effectiveness compared to semaglutide such as Wegovy.